A new Northwestern Medicine study invited users to track their long COVID-19 symptoms over time through an interactive mobile app, which curbed tracking struggles for patients. “Your doctor is not ...

SARS-CoV-2 is super contagious, and researchers don’t yet know all the reasons why. But by comparing this new virus to the ...

Is this a sign of another pandemic? After WHO confirmed 2 cases of the highly lethal Nipah virus in India, airports across the world are on high alert. Compulsory screening and mandatory isolation - ...

Results highlight the possibility of using a blood test to identify people at increased risk of chronic lung disease ...

Courts have been botching 1905 precedent upholding mandate for vaccine that actually stops transmission since Buck v. Bell, which upheld forced sterilization of "imbeciles," and especially in COVID ...

SARS-CoV-2 is a new kind of coronavirus that appeared suddenly in late 2019. The disease it causes, called COVID-19, is now showing signs that it's able to spread outside of its place of origin. This ...

It’s a bad viral season in the state, and the number of children immunized against COVID has declined sharply.

Scientists investigating the mysteries of SARS-CoV-2 are finding subtle differences in brain structure among babies exposed to the virus before they were born. They say their findings underscore the ...

Federal officials in May 2023 declared an end to the national COVID pandemic. But more than 2 years later, a growing body of ...

"SK bioscience begins international Phase I/II trial for GBP511 vaccine" was originally created and published by Clinical Trials Arena, a GlobalData owned brand.

This article examines the state of public health in the United States in January 2026, detailing mass COVID-19 infection, excess deaths, collapsing vaccination coverage, immune damage and the ...

The renewed and expanded agreements provide improved commercial conditions, including more competitive pricing, optimized ...